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The search for new natural products is leading to the isolation of novel actinomycete species, many of which
will ultimately require genetic analysis. Some of these isolates will likely exhibit low intrinsic frequencies of
homologous recombination and fail to sporulate under laboratory conditions, exacerbating the
construction of targeted gene deletions and replacements in genetically uncharacterised strains. To facilitate
the genetic manipulation of such species, we have developed an efficient method to generate gene or gene
cluster deletions in actinomycetes by homologous recombination that does not introduce any other changes
to the targeted organism’s genome. We have synthesised a codon optimised I-SceI gene for expression in
actinomycetes that results in the production of the yeast I-SceI homing endonucleasewhich produces double
strand breaks at a unique introduced 18 base pair recognition sequence. Only those genomes that undergo
homologous recombination survive, providing a powerful selection for recombinants, approximately half of
which possess the desired mutant genotype. To demonstrate the efficacy and efficiency of the system, we
deleted part of the gene cluster for the red-pigmented undecylprodiginine complex of compounds in
Streptomyces coelicolor M1141. We believe that the system we have developed will be broadly applicable
across a wide range of actinomycetes.
A
ctinomycetes are Gram-positive mycelial bacteria with a high genomic GC content that produce a wide
variety of industrially and medically relevant compounds including chemotherapeutics, fungicides, her-
bicides, immunosuppressants andmany clinically used antibiotics. The search for new pharmacologically
active and industrially relevant natural products has led to the recent isolation of many novel actinomycete
strains, many of which are recalcitrant to genetic manipulation.
Homologous recombination is a highly conserved process present in all forms of life, from bacteria to eukar-
yotes1. It is used regularly to target gene replacement and deletion in a wide range of organisms including
bacteria2, although the efficiency of this process is very much dependent on the propensity of the targeted
organism to carry out homologous recombination.
Gene deletion, replacement or disruption in bacteria generally involves the use of a non-replicative vector
carrying the targetedDNA,with selection for antibiotic resistance resulting in integration of the construct into the
host’s genome by homologous recombination (yielding the first cross-over recombinant). The resulting strain is
then screened for loss of the resistance marker carried on the vector, and the sensitive isolates obtained screened
phenotypically and/or by PCR to identify the required second cross-over recombinant. In organisms with a low
intrinsic level of homologous recombination, screening for loss of antibiotic resistance can be a very tedious
process, and in mycelial actinomycetes that do not sporulate, sometimes extremely difficult if not impossible to
achieve. To expedite this process and to select for this second recombination event, it is possible to induce a DNA
double-strand break adjacent to a targeted locus by using a meganuclease such as I-SceI. I-SceI is a monomeric
235 amino acid homing endonuclease encoded in the mitochondrial DNA of Saccharomyces cerevisiae3 which is
able to cut double stranded DNA at an 18 bp recognition sequence: TAGGGATAACAGGGTAAT. The length of
this sequence ensures that it is absent from all actinomycete genome sequences determined thus far.
Chromosome repair and viability can only result through homologous recombination between duplicated
regions of the genome, thus providing a selection for the second cross-over event which should yield a mixture
of both the original genotype and the required mutant.
Lu et al.4 previously reported the successful exploitation of the I-SceImeganuclease in Streptomyces coelicolor to
delete the gene cluster for the blue-pigmented polyketide antibiotic actinorhodin using a two plasmid system in
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resistance gene, in the genome of the targeted organism once the
required second cross-over recombinant had been obtained. This
precludes the subsequent use in the mutant of any vector that relies
on the widely-used integration system of the Streptomyces phage
WC31, and eliminates the further use of the thiostrepton resistance
marker carried by the pSET derivative. Moreover, integration at the
WC31 attB site can considerably reduce the level of production of
some specialised metabolites, including antibiotics6.
Here we report a I-SceI-based mutagenesis strategy that enables
the construction of marker-less deletions of genes and gene clusters
Figure 1 | Overview of the protocol developed to obtain marker-less gene deletions in actinomycetes. pIJ12738 containing the I-SceI recognition
sequence (shown by a pink circle) and the flanking regions (in this example, trkA and redW, corresponding to the left and right flanking regions of redD
and redX, respectively) of the chromosomal region to be deleted was conjugated intoM1141. Apramycin resistant exconjugants were analysed by PCR to
confirm integration of the plasmid (in this schematic, integration occurred by homologous recombination at trkA). A single exconjugant
(M1141Dred_int) was selected as recipient of the delivery vectors pIJ12739 and pIJ12742 expressing the I-SceI meganuclease gene. After conjugation, the
plate was overlaid with thiostrepton to select for exconjugants. I-SceI creates double strand breaks at its introduced recognition sequence, and the only
genomes to survive are those that undergo homologous recombination to reconstitute an intact chromosome. If recombination occurs in the same
flanking region that was used in the first cross-over event (in this example, trkA), then the exconjugant will revert to a wild type genotype. In contrast, if
recombination takes place in the other flanking region (in our example, redW), the exconjugant will have amutant genotype. Exconjugants were analysed
by PCR to confirm the requiredmutant genotype. To ensure loss of the I-SceI delivery vector, the mutant strain was grown at 37uC, and loss of the vector
confirmed by PCR.
www.nature.com/scientificreports
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that is applicable to many actinomycete species, and that should be
particularly useful for strains that are difficult to manipulate genetically.
Results
Validating the system with a marker-less deletion in S. coelicolor.
To validate the system and assess its efficiency, we chose to delete an
essential region of the undecylprodiginine (Red) biosynthetic gene
cluster of S. coelicolor that contained the cluster-situated regulatory
gene redD and the polyketide synthase gene redX (Fig. 17;). Red is a
red-pigmented tripyrrole compound that remains associated with
the mycelium, thus providing a facile visual screen for loss of Red
production and a quantitative estimation of deletion frequency.
First cross-over in one of the homologous regions flanking redDX.
Streptomyces coelicolor M11418 is a derivative of S. coelicolor M1459
in which the gene cluster for production of the blue-pigmented
polyketide antibiotic actinorhodin has been deleted. Thus colonies
of M1141 are red in appearance, while derivatives that are unable to
produce Red would be cream in colour.
pIJ12740, containing sequences flanking redD (trkA) and redX
(redW) and the adjacent I-SceI recognition site, was introduced
into S. coelicolor M1141 from Escherichia coli by conjugation.
Apramycin-resistant exconjugants, all pigmented due to their ability
to synthesise Red, were isolated and the presence of the non-
replicative plasmid confirmed by PCR. Integration by homologous
recombination through trkA was confirmed for some of the excon-
jugants using primers corresponding to the chromosomal sequence
to the left of trkA (as shown in Fig. 1) and to a sequence internal to
redW (data not shown). One of these exconjugants was designated
M1141Dred_int (for Dred integrant).
Figure 2 | Restrictionmaps of the plasmids constructed in this study. aac(3)IV, apramycin resistance gene; ori, E. coli origin of replication; oriT, origin of
transfer; MCS, multiple cloning site; lacZ, a fragment of lacZ; rep, origin of replication from pSG5; tsr, thiostrepton resistance gene; fd, transcriptional
terminator from phage fd; to, transcriptional terminator; tipAp, thiostrepton inducible tipA promoter; ermE*p, mutated constitutive promoter from
ermE.
www.nature.com/scientificreports
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Delivery and expression of I-SceI to select for the second homo-
logous recombination event. To select for second cross-over
recombinants, pIJ12739 (Fig. 2), containing the codon optimised I-
SceI gene under the control of the thiostrepton inducible tipA
promoter, was introduced into M1141Dred_int by conjugation
from E. coli and exconjugants selected by overlaying the agar plate
with thiostrepton. Spores were collected directly from the
conjugation plate, diluted and plated on R5 agar containing
nalidixic acid (to prevent growth of the E. coli donor strain) and
the number of red and cream colonies on each plate counted
(Fig. 3). After examining over 2000 exconjugants from each of four
independent matings, the frequency of colonies displaying a Red2
phenotype after the second crossover event varied between 29 and 52
percent. Ten cream and ten red colonies were analysed by PCR to
confirm deletion of redDX in the cream isolates (M1141Dred),
reversion to the wild type genotype in the red colonies (Fig. 3), and
loss of the pIJ12740 backbone by homologous recombination in all of
them (data not shown).
Induction of the tipA promoter by thiostrepton requires the pres-
ence of the tipA gene10, which is not present in all actinomycetes. As
an alternative strategy, and to overcome this potential limitation,
pIJ12742 (Fig. 2), containing the codon optimised I-SceI gene under
the control of the strong constitutive ermE* promoter, was delivered
to the first cross-over recombinant following exactly the same pro-
tocol as described above for pIJ12739. After screening over 2000
colonies from each of three independent conjugations, the frequency
of colonies displaying a Red2 mutant phenotype varied between 27
and 49 percent, similar to the results obtained with pIJ12739. Again,
ten of the cream and ten of the red colonies were analysed by PCR to
verify that the phenotype of the colony corresponded to the predicted
genotype (Fig. 3) and that the pIJ12740 backbone had been lost by a
second homologous recombination event.
Loss of the temperature-sensitive I-SceI delivery vectors pIJ12739
and pIJ12742. Both pIJ12739 and pIJ12742 are derivatives of
pGM1190, an intermediate copy number, conjugative plasmid
containing the temperature-sensitive replication origin of pSG511.
When exconjugants carrying either pIJ12739 or pIJ12742 are
grown above 34uC, the plasmids are unable to replicate and are
lost. After plasmid curing, the exconjugants can be grown at their
Figure 3 | Phenotype and genotype verification of wild type and mutant exconjugants of M1141Dred_int. R5 agar plates containing exconjugants
resulting from conjugation of either pIJ12739 (top) or pIJ12742 (bottom). Colony PCR (to the right of each agar plate) carried out on ten red (M1141
with intact red gene cluster, expected fragment size 2697 bp), and ten cream (M1141Dred, expected fragment size 160 bp) randomly selected
exconjugants confirmed that the phenotypes corresponded to the presence or absence of redDX, respectively. M1, 1 kb ladder (New England Biolabs);
M2, 100 bp ladder (New England Biolabs). WT, genomic DNA from M1141 used as a control.
Table 1 | Strains and plasmids used in this study
Strain/Plasmid Genotype/Description Reference
Escherichia coli DH5a F2 Q80 lacZDM15 D(lacZYA-argF )U169 recA1 endA1 hsdR17
(rk2, mk1) phoA supE44 thi-1 gyrA96 relA1 l2
InvitrogenTM
E. coli ET12567 dam-13::Tn9 dcm-6 hsdM CmlR, carrying helper plasmid pUZ8002 22
S. coelicolor M1141 M145 derivative Dact 8
S. coelicolor M1141Dred_int M1141 containing pIJ12740 This study
S. coelicolor M1141Dred M1141 DredDX This study
pUC57-Simple_SceI pUC57-Simple with tcp830p-I-SceI gene-fd terminator-MCS-I-SceI site GeneScript (Piscataway, USA)
pKC1132 Conjugative vector, non-replicative in Streptomyces, AprR 5
pIJ12738 pKC1132 with MCS and I-SceI site from pUC57-Simple_SceI This study
pGM1190 tsr (ThiR), aac(3)IV (AprR), oriT, to terminator, tipAp, RBS, fd terminator 11
pIJ12739 pGM1190 with tipAp-I-SceI gene, ThiR This study
pIJ12551 Conjugative and QC31-integrative vector, AprR 19
pIJ12590 pIJ12551 with I-SceI gene This study
pIJ12742 pGM1190 with ermE*p-I-SceI gene, ThiR This study
pIJ12740 pIJ12738 with redXW left and right flanking sequences This study
www.nature.com/scientificreports
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lower optimal temperature. Growth of ten red and ten cream
colonies containing each of the I-SceI delivery plasmids on SFM
agar at 37uC resulted in complete loss of each of the pGM1190
derivatives, confirmed by their sensitivity to thiostrepton and PCR
analysis (data not shown). Thus, after growth at the non-permissive
temperature, all of the M1141Dred exconjugants with a marker-less
deletion of redDX had also lost the nuclease delivery vector, leaving a
mutant with no introduced DNA or antibiotic resistance markers.
Interestingly, when S. coelicolor M1141Dred derivatives carrying
either pIJ12739 or pIJ12742 were passaged through two rounds of
sporulation at 30uC in the absence of thiostrepton, 60 percent of the
resulting colonies were sensitive to the antibiotic suggesting loss of
the plasmids, which was confirmed by PCR analysis (data not
shown). This inherent instability in the absence of antibiotic selec-
tion could be useful when working with any strains that may not be
able to grow at higher temperatures.
Discussion
In bacteria, double stranded breakage of the chromosome is a lethal
event unless the lesion is repaired by homologous recombination.
We have taken advantage of the mitochondrial homing endonu-
clease I-SceI to select for second cross-over recombinants, with 27–
52 percent yielding the required mutational event. In this study, we
have demonstrated the utility of this approach by constructing a two
plasmid system to create a marker-less deletion in S. coelicolor. This
system has also been used to efficiently delete, in an iterative manner,
entire gene clusters from the genome of Streptomyces venezuelae
(Neil Holmes, personal communication). In this study we used con-
jugation from E. coli for plasmid transfer (conjugation is the most
widely-used procedure for introducing DNA into actinomycetes),
but in principle protoplast transformation could be used instead with
targeted strains for which conjugation protocols do not yet exist. In
addition to being readily applicable to well-studied academic and
industrial strains (where there is clear potential for use in the con-
struction of engineered strains with improved expression of hetero-
logous genes and gene clusters), we believe that the system described
here will be particularly useful when attempting to make mutants in
novel and genetically uncharacterised actinomycetes, especially if
they exhibit low levels of homologous recombination and/or fail to
sporulate, which generally provides a very useful means of segreg-
ating wild type and mutant genomes in a multi-nucleoid mycelial
organism. If dealing with a non-sporulating strain, mycelia from
each of the conjugation plates could be harvested, fragmented (for
example, by using a Potter homogeniser) and then subjected to the
same protocol.
Methods
Bacterial strains, plasmids and generalmethods.The strains and plasmids used and
generated in this study are listed in Table 1. Plasmid isolation, PCR amplification and
E. coli growth and manipulation were carried out following standard methods12–14. S.
coelicolor strains were grown on SFM and R5 agar as described previously9.
Plasmid construction. Oligonucleotides generated and used in this study are
described in Table 2. DNA manipulation and cloning were carried out according to
standard protocols12. Plasmid constructs were confirmed by sequencing. A fragment
containing the tcp830 promoter15, followed by the synthetic I-SceI gene codon
optimised for actinomycetes, the Streptomyces lividans multi-copy plasmid pIJ101
terminator region16, a multiple cloning site (MCS) containing the following unique
sites: SacII, NotI, XbaI, SpeI, PstI, EcoRI and EcoRV and the I-SceI 18 bp recognition
sequence was synthesised by GeneScript (Piscataway, USA) and flanked by HindIII
and MfeI restriction sites. The fragment was provided on the plasmid pUC57-
Simple_SceI. This plasmid was treated with XbaI and SspI, and the 117 bp fragment
containing theMCS followed by the I-SceI recognition site was cloned into pKC11325
cut with XbaI and EcoRV to generate pIJ12738 (Fig. 2).
To construct the plasmid carrying the codon optimised I-SceI gene, pUC57-
Simple_SceI was cut with NdeI and EcoRI to generate a 853 bp fragment that was
cloned into pGM119011 cleaved with the same enzymes. This generated pIJ12739
(Fig. 2) in which the I-SceI gene is under the control of the inducible tipA promoter17.
To express the I-SceI gene from the strong constitutive ermE* promoter18, a 806 bp
NdeI-SacII fragment containing the gene was excised from pIJ12739 and cloned into
pIJ1255119 digested with the same enzymes to generate pIJ12590. A 1055 bp fragment
containing ermE*p-I-SceI gene was amplified by PCR using oligonucleotides con-
taining SnaBII or EcoRI restriction sites (Table 2). This fragment was cloned into
pGM1190 digested with the same enzymes to generate pIJ12742 (Fig. 2).
Construction of deletion mutants. Chromosomal regions flanking the adjacent
cluster-situated regulatory gene redD and the polyketide synthase gene redX of the
undecylprodiginine (Red) biosynthetic gene cluster were amplified by PCR and
cloned into pIJ12738. Both genes are essential for Red biosynthesis20,21. The flanking
region 59 of redD was amplified to generate a 1516 bp fragment with terminal XbaI
and BamHI sites and the region 39 of redX was amplified to generate a 1419 bp
fragment with terminal BamHI and KpnI sites. These two flanking fragments were
cloned into pIJ12738 digested with XbaI and KpnI to generate pIJ12740 with the I-
SceI site adjacent to the introduced red gene fragments. pIJ12740 was then introduced
into E. coli ET12567/pUZ800222 by transformation. Conjugation between E. coli
ET12567/pUZ8002 carrying the oriT-containing plasmid and Streptomyces coelicolor
M1141 was carried out as previously described9. Chromosomal integration of
pIJ12740 generated M1141Dred_int which was still capable of Red production.
pIJ12739 or pIJ12742 carrying the I-SceI gene was then conjugated into
M1141Dred_int to induce a double strand break at the introduced I-SceI site. Ten
individual red and cream colonies isolated from each of the conjugations were
streaked on SFMagar and grown at 37uCuntil sporulation. Spores were harvested and
plated on SFM agar with or without thiostrepton. No colonies grew in the presence of
thiostrepton, indicative of plasmid loss, which was confirmed by PCR analysis (data
not shown).
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